( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
119124.4
115363.2
114542.3
106983.1
Total Expenditure
31090.4
30623.4
32932.2
30331.4
PBIDT (Excl OI)
88034
84739.8
81610.1
76651.7
Other Income
88.9
61.2
60.2
71.6
Operating Profit
88122.9
84801
81670.3
76723.3
Interest
55248.3
54007.6
52239.9
47512.6
Exceptional Items
NA
NA
NA
15536.6
PBDT
32874.6
30793.4
29430.4
44747.3
Depreciation
1745
1731.1
1710.6
1619.2
Profit Before Tax
31129.6
29062.3
27719.8
43128.1
Tax
8031.6
7509.8
6325.9
10807.4
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
23098
21552.5
21393.9
32320.7
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
23097.5
21552
21393.9
32452.6
Minority Interest
0.1
0.1
0.00
-17.9
Shares of Associates
44.1
41.9
43.8
33.8
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
23141.7
21594
21437.7
32468.5
Equity Capital
3762
3761.3
3760.8
3760.6
Calculated EPS
12.30
11.48
11.40
17.26
Calculated EPS (Annualised)
49.21
45.92
45.60
69.07
No of Public Share Holdings
1403426503
1403061844
1402802500
280542501
% of Public Share Holdings
74.61
74.61
74.6
74.6
PBIDTM% (Excl OI)
73.90
73.45
71.24
71.64
PBIDTM%
73.97
73.50
71.30
71.71
PBDTM%
27.59
26.69
25.69
41.82
PBTM%
26.13
25.19
24.20
40.31
PATM%
19.38
18.68
18.67
30.21